Medical Weight-Loss 2.5mg Programme
Entry-level dosage within the clinician-led Medical Weight Loss Programme.
Prescription-based treatment • Medical assessment required
Programme Overview
The 2.5mg dosage is typically prescribed as an initial treatment level within the Medical Weight Loss Programme. It allows patients to begin prescription-based therapy, including Mounjaro, under medical supervision while the body adjusts to treatment.
Supportive IV therapy is incorporated to assist with hydration, nutrient balance, and overall wellbeing during the early stages of treatment.
Dosage Overview
-
Often prescribed as a starting dosage
-
Determined through clinical assessment
-
May be adjusted based on individual response
-
Forms part of a structured, supervised treatment plan
What’s Included
-
Prescription-based treatment including Mounjaro (as clinically indicated)
-
Supportive Weight-Loss Support IV infusion
-
Ongoing monitoring and dosage review
-
Access to clinician-guided adjustments
Choose your weight loss programme
Mounjaro 2.5 mg + Weight-Loss Support IV
3-Month Plan
R19,773
Clinician-led subscription programme combining prescription treatment with supportive IV therapy to maintain hydration, nutrient balance, and energy levels throughout the programme.
Four combined Mounjaro and Weight-Loss Support treatment is administered each month for three months.
Suitable for initiating treatment under medical supervision.
Weight-Loss Support IV Infusion
3-Month Plan
R6,900
This Weight-Loss Support IV infusion complements prescribed Mounjaro therapy by delivering essential vitamins, amino acids, and metabolic nutrients directly into the bloodstream to support hydration, nutrient balance, and energy levels throughout treatment.
Four IV infusions per month are delivered throughout each three-month phase of the programme.
Designed for initiating IV metabolic support under medical supervision.
One-time payment • Secure checkout • Subscription active for selected duration
Best Value Programme
9-Month Metabolic Transformation Programme
A complete, clinician-guided treatment pathway designed to support sustained weight loss through structured Mounjaro dose escalation and monthly IV metabolic support.
Programme Structure
Each month includes four combined Mounjaro + Weight-Loss Support IV treatments, delivered weekly.
Over the full program, patients receive 36 treatments across 9 months, progressing through the 2.5 mg, 5 mg, and 7.5 mg dosage phases under clinical supervision.
2.5 mg Initiation Phase
Months 1–3
Introduces Mounjaro at a lower dose to allow the body to adapt to treatment while beginning metabolic and appetite regulation under clinical supervision.
Months 4–6
5 mg Progression Phase
The dosage is increased to maintain treatment effectiveness and support continued metabolic response as the body adjusts to therapy.
Months 7–9
7.5 mg Advanced Phase
A further increase in dosage helps sustain therapeutic impact and supports ongoing weight-management progress during the later stage of the programme.
12 Treatments delivered during this phase
12 Treatments delivered during this phase
12 Treatments delivered during this phase
Each monthly session includes a Weight-Loss Support IV infusion to help maintain hydration, nutrient balance, and energy levels throughout treatment.